MARKET

RDY

RDY

Dr.Reddys
NYSE

Real-time Quotes | Nasdaq Last Sale

40.45
-0.81
-1.96%
After Hours: 40.45 0 0.00% 16:00 12/13 EST
OPEN
40.28
PREV CLOSE
41.26
HIGH
40.62
LOW
40.17
VOLUME
202.40K
TURNOVER
--
52 WEEK HIGH
42.82
52 WEEK LOW
34.67
MARKET CAP
6.71B
P/E (TTM)
17.81
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RDY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RDY News

  • Hedge Funds Are Piling Into Dr. Reddys Laboratories Limited (RDY)
  • Insider Monkey.1d ago
  • Dr. Reddy's launches Deferasirox oral suspension and film-coated tablets in U.S.
  • Seeking Alpha - Article.12/06 11:26
  • Dr. Reddy's Laboratories Announces the Launch of Deferasirox Tablets for Oral Suspension, in the U.S. Market
  • Business Wire.12/06 08:29
  • Dr. Reddy's launches bortezomib for injection in U.S.
  • Seeking Alpha - Article.12/04 11:40

More

Industry

Pharmaceuticals
-0.74%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About RDY

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
More

Webull offers Dr.Reddy's Laboratories Ltd (ADR) (RDY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.